Application of oleanolic acid in preparation of medicine for treating obesity
A technology for oleanolic acid and obesity, applied in the field of medicine, can solve the problem of unclear regulation of miR-26a expression
Image
Examples
Embodiment Construction
[0030] The present invention will discuss the role of TGR5 as the main receptor (not the only receptor) of the natural compound OA in anti-obesity and blood sugar reduction. TGR5 can increase the expression of miR-26a in macrophages through a JNK-dependent signaling pathway, but FXR cannot. This novel association of TGR5 with miR-26a could enhance the metabolic effects of OA.
[0031] The main English abbreviations in this manual are compared with Chinese terms: BA, bile acid; CA, cholic acid; DCA, deoxycholic acid; OA, oleanolic acid; HFD, high-fat diet; GP-BAR1, G-protein bile acid-activated receptor; FXR, farnesoid receptor; T2D , type 2 diabetes; JNK, c-jun amino-terminal kinase; MAPK, mitogen-activated protein kinase; ERK1 / 2, extracellular regulated protein kinase.
[0032] Materials and Methods
[0033] Animal Feeding and Handling
[0034] C57BL / 6 and JNK1 knockout mice were purchased from Jackson Laboratory. TGR5 - / -Mice were kindly provided by Dr. Vassileva ...
PUM
Login to View More Abstract
Description
Claims
Application Information
- IPC
- A61K31/56; A61P3/04; A61P3/10
- Inventors
- 陈小松; 傅湘辉
